Add office photos
Employer?
Claim Account for FREE
Aurobindo Pharma
4.0
based on 4.8k Reviews
Video summary
Company Overview
Associated Companies
Company Locations
Working at Aurobindo Pharma
Company Summary
Aurobindo Pharma operates in the pharmaceutical sector, specializing in cost-efficient manufacturing of active ingredients and formulations across diverse therapeutic areas.
Overall Rating
4.0/5
based on 4.8k reviews
3% above
industry average
Highly rated for
Job security, Salary, Work-life balance
Work Policy
Work from office
89% employees reported
Monday to Saturday
59% employees reported
Strict timing
53% employees reported
No travel
44% employees reported
View detailed work policy
Top Employees Benefits
Job/Soft skill training
255 employees reported
Health insurance
244 employees reported
Office cab/shuttle
182 employees reported
Cafeteria
83 employees reported
View all benefits
About Aurobindo Pharma
Founded in1986 (39 yrs old)
India Employee Count10k-50k
Global Employee Count10k-50k
India HeadquartersHyderabad/Secunderabad, Telangana, India
Office Locations
--
Websiteaurobindo.com
Primary Industry
Other Industries
Are you managing Aurobindo Pharma's employer brand? To edit company information,
claim this page for free
View in video summary
Founded in 1986 by Mr. P.V. Ramprasad Reddy, Mr. K. Nityananda Reddy and a small group of highly committed professionals, Aurobindo Pharma was born of a vision. The company commenced operations in 1988-89 with a single unit manufacturing Semi-Synthetic Penicillin (SSP) at Pondicherry. Aurobindo Pharma became a public company in 1992 and listed its shares on the Indian stock exchanges in 1995. In addition to being the market leader in Semi-Synthetic Penicillin’s, Aurobindo Pharma has a presence in key therapeutic segments such as neurosciences (CNS), cardiovascular (CVS), anti-retroviral, anti-diabetics, gastroenterology and Anti-biotics Through cost effective manufacturing capabilities and a few loyal customers, the company also entered the high margin specialty generic formulations segment. Today Aurobindo Pharma has evolved into a knowledge driven company manufacturing active pharmaceutical ingredients and formulation products. It is R&D focused and has a multi-product portfolio with manufacturing facilities in several countries.
Mission: Aurobindo’s mission is to become the most valued Pharma partner to the World Pharma fraternity by continuously researching, developing and manufacturing a wide range of pharmaceutical products that comply with the highest regulatory standards.
Vision: To build a leading global generic pharma company and become one of the top 10 by 2020.
Managing your company's employer brand?
Claim this Company Page for FREE
Brands of Aurobindo Pharma
Apis India
3.6
• 134 reviews
AuroZymes
3.0
• 1 review
Aurobindo Pharma Ratings
based on 4.8k reviews
Overall Rating
4.0/5
How AmbitionBox ratings work?
5
2.3k
4
1.5k
3
583
2
215
1
308
Category Ratings
4.3
Job security
3.8
Salary
3.8
Work-life balance
3.7
Work satisfaction
3.6
Company culture
3.6
Skill development
3.5
Promotions
Aurobindo Pharma is rated 4.0 out of 5 stars on AmbitionBox, based on 4.8k company reviews. This rating reflects a generally positive employee experience, indicating satisfaction with the company’s work culture, benefits, and career growth opportunities. AmbitionBox gathers authentic employee reviews and ratings, making it a trusted platform for job seekers and employees in India.
Read more
Gender Based Ratings at Aurobindo Pharma
based on 4.6k reviews
4.0
Rated by 227 Women
Rated 4.2 for Job security and 3.7 for Work-life balance
4.0
Rated by 4.4k Men
Rated 4.3 for Job security and 3.9 for Salary
Work Policy at Aurobindo Pharma
based on 566 reviews in last 6 months
Work from office
89%
Hybrid
7%
Permanent work from home
4%
Aurobindo Pharma Reviews
Top mentions in Aurobindo Pharma Reviews
+ 5 more
Compare Aurobindo Pharma with Similar Companies
Change Company | Change Company | Change Company | ||
|---|---|---|---|---|
Overall Rating | 4.0/5 based on 4.8k reviews | 4.0/5 based on 6.9k reviews | 4.1/5 based on 6.1k reviews | 4.1/5 based on 7k reviews |
Highly Rated for | Job security Work-life balance Salary | Skill development Company culture Work-life balance | Skill development Company culture Work-life balance | Skill development Salary Work-life balance |
Critically Rated for | No critically rated category | No critically rated category | No critically rated category | No critically rated category |
Primary Work Policy | Work from office 89% employees reported | Work from office 74% employees reported | Work from office 85% employees reported | Work from office 74% employees reported |
Rating by Women Employees | 4.0 Good rated by 227 women | 4.0 Good rated by 782 women | 4.0 Good rated by 372 women | 4.0 Good rated by 704 women |
Rating by Men Employees | 4.0 Good rated by 4.4k men | 4.1 Good rated by 5.8k men | 4.2 Good rated by 5.5k men | 4.1 Good rated by 6k men |
Job security | 4.3 Good | 3.6 Good | 3.7 Good | 3.7 Good |
View more
Aurobindo Pharma Salaries
Aurobindo Pharma salaries have received with an average score of 3.8 out of 5 by 4.8k employees.
Technical Assistant
(1.2k salaries)
Unlock
₹1.6 L/yr - ₹6.8 L/yr
Deputy Manager
(515 salaries)
Unlock
₹7 L/yr - ₹17.5 L/yr
Senior Technical Assistant
(378 salaries)
Unlock
₹3.5 L/yr - ₹8.3 L/yr
Research Associate
(283 salaries)
Unlock
₹2.2 L/yr - ₹10.6 L/yr
Executive Production
(221 salaries)
Unlock
₹1.8 L/yr - ₹9 L/yr
Senior Chemist
(185 salaries)
Unlock
₹2.6 L/yr - ₹7 L/yr
Scientist
(183 salaries)
Unlock
₹6 L/yr - ₹14.5 L/yr
Research Associate IV
(169 salaries)
Unlock
₹3.4 L/yr - ₹9.4 L/yr
Executive Engineer
(147 salaries)
Unlock
₹2.8 L/yr - ₹8.6 L/yr
QA Executive
(139 salaries)
Unlock
₹2.5 L/yr - ₹8 L/yr
Aurobindo Pharma Interview Questions
Interview questions by designation
Top Aurobindo Pharma interview questions and answers
Get interview-ready with top interview questions
Aurobindo Pharma Jobs
Popular Designations Aurobindo Pharma Hires for
Popular Skills Aurobindo Pharma Hires for
Current Openings
Aurobindo Pharma News
View all
What do Trump’s tariffs mean for Indian auto, pharma and steel stocks?
- US President Donald Trump's focus on reshoring manufacturing is evident, with potential risks to the economy.
- Reciprocal tariffs set to begin on April 2 may impact sectors like auto, pharma, and steel in India.
- Indian auto OEMs may remain unaffected by US tariffs while auto ancillary players might face a second-order impact.
- Pharma trade between India and the US may be affected by reciprocal tariffs, impacting formulation makers.
- Indian companies like Aurobindo Pharma and Dr. Reddy's may face challenges from US-based competitors due to tariffs.
- US tariffs on steel imports may have minimal impact on Indian steel exports due to their small contribution.
- Indian steel producers like Jindal Steel and JSW Steel may face indirect negative impacts from global tariff barriers.
- India's move to impose a provisional safeguard duty on steel imports aims to protect the domestic steel industry.
- The steel sector in India has seen declining realizations, prompting the need for protective measures against import surges.
- Overall, various sectors in India are bracing for potential repercussions and uncertainties due to the evolving global trade scenario.
HinduBusinessLine | 22 Mar, 2025
Stocks To Watch Today: IIFL Finance, Piramal Enterprises, Dalmia Bharat, NCC, Indian Overseas Bank
- IIFL Finance, Piramal Enterprises, Dalmia Bharat, NCC, Indian Overseas Bank are some stocks to watch today.
- Other stocks to watch include RailTel, Ujjivan Small Finance Bank, MSTC, Vishnu Prakash R Punglia, and Aurobindo Pharma.
- IIFL Finance approved the issuance of secured, rated, redeemable debentures through a private placement.
- Piramal Enterprises received a GST demand of Rs 1,502 crore from the Maharashtra tax authority.
Bloomberg Quint | 3 Mar, 2025
Stock Market Today: All You Need To Know Going Into Trade On Feb. 19
- Indian stock market indices closed slightly lower on Tuesday with IT and oil companies gaining, while consumer durables and autos faced pressure.
- Foreign portfolio investors turned net buyers after nine consecutive selling sessions, purchasing stocks worth around Rs 4,786.6 crore.
- Domestic institutional investors continued to be net buyers for the 10th straight session, acquiring equities worth Rs 3,072.2 crore.
- The Indian rupee weakened, closing at 86.95 against the US dollar on Tuesday.
- Stocks to watch included Container Corp, L&T, Transformers and Rectifiers India, Punjab National Bank, Aurobindo Pharma, and more, due to various developments and news.
- In IPO news, shares of Hexaware Tech debuted on the stock exchanges, while Quality Power Electrical Equipments saw good subscription levels in its public issue.
- Various block deals, insider trading activities, trading tweaks, and F&O cues were also reported, providing insights into market activities.
- Nifty futures and options data indicated market sentiment and price band changes for different companies were observed.
- Overall, the stock market today reflected mixed performances across sectors and highlighted significant developments affecting various stocks.
- For more detailed information, refer to the original article on NDTV Profit.
Bloomberg Quint | 19 Feb, 2025
Stocks that will see action today: February 14, 2025
- Aurobindo Pharma's subsidiary, CuraTeQ Biologics, has received marketing authorization in the EU for filgrastim biosimilar, Zefylti.
- Ugro Capital raises ₹260 crore from FMO to support women's empowerment, address territorial inequalities, and foster youth empowerment.
- RBL Bank's CEO, R Subramaniakumar, receives RBI approval for re-appointment for three years.
- TVS Motor Company acquires additional shares of TVS Supply Chain Solutions in a ₹107 crore open market transaction.
HinduBusinessLine | 14 Feb, 2025
Cummins, Aurobindo, Alkem Labs, Bajaj Electricals, HG Infra, PSP Projects, NOCIL Q3 Review — HDFC Securities
- The brokerage recommends 'Buy' rating on Cummins, HG Infra, Bajaj Electricals, and 'Add' on Aurobindo, Alkem Labs, PSP Projects, NOCIL
- Cummins has multiple tailwinds, namely, stringent emission norms, capex cycle recovery, adoption of alternative fuels with lower carbon footprint, revival in industrials and exports, and support for manufacturing policies. We maintain Buy, with a revised SOTP of Rs 4,597 (54x Dec-26 EPS).
Bloomberg Quint | 8 Feb, 2025
Stocks that will see action today: February 1
- Hero MotoCorp appoints Vikram Kasbekar as acting CEO, Niranjan Gupta to step down
- Onesource Specialty Pharma promoters divest 6.8% stake for Rs 1,202 crore
- CL Educate acquires Digital Exam Assessment business of NSEIT
- Aurobindo Pharma's subsidiary receives positive opinion for Dyrupeg from CHMP
HinduBusinessLine | 1 Feb, 2025
Stock Market On Budget Day: All You Need To Know Going Into Trade On Feb. 1
- Both NSE and BSE will remain open on Saturday, Feb. 1 on account of the Budget Day.
- Indian equity benchmark indices closed higher four days in a row, Nifty ended 1.12% and BSE Sensex ended 0.97% higher.
- Foreign portfolio investors stayed net sellers of Indian equities for the 21st straight session on Friday as they sold stocks worth approximately Rs 1,189 crore.
- Earnings To Watch: Aarti Industries, Anant Raj, Ganesha Ecosphere, GR Infraprojects, Jaiprakash Power Ventures, Neogen Chemicals and Vinati Organics.
- Stocks To Watch: ONGC, Waaree Energies, Nestle India, Aurobindo Pharma, Hero MotoCorp, Punjab National Bank, Britannia, Tata Power, GAIL, Ganesha Ecosphere and Sundaram Clayton.
- Nifty February futures end 0.94% higher at a premium of 111 points.
- The Indian rupee closed flat against the US dollar on Friday at 86.62.
- Indian Finance Minister Nirmala Sitharaman will announce the Budget 2025 on Feb. 1.
- Most Asian markets will remain closed on Saturday.
- Indian stock markets will remain open on Feb. 1.
Bloomberg Quint | 1 Feb, 2025
Stocks To Buy Today: Dr Reddy's, BHEL HCC, Aurobindo Pharma And More
- Analysts have shared 'buy' calls on BHEL, HCC, Dr Reddy's, Aurobindo Pharma, IPCA Labs, and Laurus Labs.
- Some of these companies could see upside of as much as 9% in the near term from current levels.
- Top stocks to buy, as recommended by experts: Dr Reddy's Laboratories, Aurobindo Pharma, Laurus Labs, HCC, IPCA Laboratories.
- Stocks like Dr Reddy's and Aurobindo Pharma have shown significant gains in the past 12 months.
Bloomberg Quint | 30 Dec, 2024
Buy, Sell Or Hold: M&M, IOC, Asian Paints, Oil India, Varun Beverages — Ask Profit
- Market analysts provide insights for short-term and long-term investors on buying, selling, or holding shares of Shakti Pumps, Varun Beverages, and others.
- KPIT Technologies: Analyst suggests selling on rise as downside potential is expected.
- Aurobindo Pharma: Analyst recommends buying, stating it as a good stock for the long term.
- Indian Oil Corp: Analyst advises holding due to attractive dividend yield and potential upside in the long term.
- Asian Paints: Analyst suggests selling on rise as the stock shows a lower-high, lower-top pattern.
- M&M: Analyst recommends holding, citing strong sales demand and low consumption.
- Oil India: Analyst suggests holding for long term, as the stock corrects from high levels.
- Shakti Pumps: Analyst suggests selling in the short term and holding for the long term.
- Varun Beverages: Analyst advises holding, as the stock consolidates and has potential for a bullish trend.
Bloomberg Quint | 24 Dec, 2024
Aurobindo Pharma, Glenmark, Zydus Recall Products In US
- Drug makers Aurobindo Pharma, Glenmark, and Zydus are recalling products in the US market due to manufacturing issues.
- Aurobindo Pharma USA Inc. is recalling over 1 lakh bottles of Cinacalcet tablets due to the presence of N-nitroso Cinacalcet impurity above FDA recommended limit.
- Glenmark Pharmaceuticals Inc, USA is recalling around 90,000 bottles of Diltiazem Hydrochloride extended-release capsules due to the presence of N-nitroso-Desmethyl-Diltiazem impurity above FDA recommended limit.
- Zydus Pharmaceuticals (USA) Inc is recalling 4,404 packs of Esomeprazole Magnesium for Delayed-Release Oral Suspension due to a labeling error.
Bloomberg Quint | 15 Dec, 2024
Powered by
Aurobindo Pharma Subsidiaries
Eugia Pharma Specialities
4.1
• 459 reviews
APL Healthcare
3.8
• 54 reviews
Auro Peptides
4.1
• 34 reviews
Silicon Life Sciences
4.3
• 7 reviews
Tergene Biotech
1.7
• 2 reviews
APL RESEARCH CENTRE
5.0
• 2 reviews
Report error
Aurobindo Pharma Offices
Compare Aurobindo Pharma with
Zydus Lifesciences
4.1
Sun Pharmaceutical Industries
4.0
Intas Pharmaceuticals
4.1
Hetero
3.9
Viatris
4.2
Alembic Pharmaceuticals
4.0
Abbott
4.1
Glenmark Pharmaceuticals
3.9
Alkem Laboratories
3.9
Ipca Laboratories
3.9
Torrent Pharmaceuticals
3.9
Mankind Pharma
3.9
MSN Laboratories
3.7
Ajanta Pharma
4.0
Akums Drugs & Pharmaceuticals Limited
4.4
GlaxoSmithKline Pharmaceuticals
4.1
Pfizer
4.0
DIVI'S Laboratories
3.7
Wockhardt
3.9
Sanofi
4.2
Edit your company information by claiming this page
Contribute & help others!
You can choose to be anonymous
Companies Similar to Aurobindo Pharma
Cipla
Manufacturing, Pharma
4.1
• 7k reviews
Dr. Reddy's
Clinical Research, Pharma
4.0
• 6.9k reviews
Lupin
Biotech & Life sciences, Manufacturing, Pharma
4.1
• 6.1k reviews
Zydus Lifesciences
Biotech & Life sciences, Pharma
4.1
• 6.1k reviews
Sun Pharmaceutical Industries
Healthcare / Pharma, Manufacturing, Analytics & KPO, Pharma
4.0
• 5.9k reviews
Intas Pharmaceuticals
Biotech & Life sciences, Pharma
4.1
• 3.5k reviews
Alembic Pharmaceuticals
Real Estate, Engineering & Construction, Biotechnology, Pharma
4.0
• 3.1k reviews
Abbott
Healthcare / Pharma, Media & Entertainment / Publishing, Pharma
4.1
• 3.1k reviews
Glenmark Pharmaceuticals
Pharma
3.9
• 2.9k reviews
Alkem Laboratories
Healthcare / Pharma, Biotechnology, Pharma
3.9
• 2.9k reviews
Aurobindo Pharma FAQs
When was Aurobindo Pharma founded?
Aurobindo Pharma was founded in 1986. The company has been operating for 39 years primarily in the Pharma sector.
Where is the Aurobindo Pharma headquarters located?
Aurobindo Pharma is headquartered in Hyderabad/Secunderabad, Telangana.
How many employees does Aurobindo Pharma have in India?
Aurobindo Pharma currently has more than 26,000+ employees in India. Research & Development department appears to have the highest employee count in Aurobindo Pharma based on the number of reviews submitted on AmbitionBox.
Does Aurobindo Pharma have good work-life balance?
Aurobindo Pharma has a Work-Life Balance Rating of 3.8 out of 5 based on 4,800+ employee reviews on AmbitionBox. 77% employees rated Aurobindo Pharma 4 or above, while 23% employees rated it 3 or below on work-life balance. This indicates that the majority of employees feel a generally balanced work-life experience, with some opportunities for improvement based on the feedback. We encourage you to read Aurobindo Pharma work-life balance reviews for more details
Is Aurobindo Pharma good for career growth?
Career growth at Aurobindo Pharma is rated fairly well, with a promotions and appraisal rating of 3.5. 77% employees rated Aurobindo Pharma 4 or above, while 23% employees rated it 3 or below on promotions/appraisal. Though the sentiment is mixed for career growth, majority employees have rated it positively. We recommend reading Aurobindo Pharma promotions/appraisals reviews for more detailed insights.
What are the pros of working in Aurobindo Pharma?
Working at Aurobindo Pharma offers several advantages that make it an appealing place for employees. The company is highly rated for job security, salary & benefits and work life balance, based on 4,800+ employee reviews on AmbitionBox.
Stay ahead in your career. Get AmbitionBox app
Helping over 1 Crore job seekers every month in choosing their right fit company
75 Lakh+
Reviews
5 Lakh+
Interviews
4 Crore+
Salaries
1 Cr+
Users/Month
Contribute to help millions
Get AmbitionBox app
Made with ❤️ in India. Trademarks belong to their respective owners. All rights reserved © 2024 Info Edge (India) Ltd.
Follow us
